Will expand r&d capabilities with five-year investment of €76m from Irish government
Generic pharmaceuticals manufacturer Mylan is to expand its operations in Dublin and Galway in Ireland over the next five years following investment of up to €76m (US$100m) from the Irish government through the Irish Development Authority.
The investment includes funding for expanded research and development (r&d) capabilities and manufacturing capabilities within its respiratory, injectables and oral solids franchises.
Mylan says it will create more than 500 new jobs in Ireland by 2016. About 220 will be based at Mylan’s Bioniche Pharma operation in Galway with the remainder at Gerard Laboratories in Dublin.
The company currently employs around 700 people at its facilities in Ireland.
Heather Bresch, chief executive of Mylan, said: ‘This investment in Mylan’s Irish operations and the growth of our capabilities in the country demonstrate our continued commitment to and confidence in our respiratory franchise and injectables platform, both of which are among Mylan's many long-term growth drivers.’